Subsequently, the results of supervised models of partial least squares-discriminant analysis (PLS-DA) (Fig. 1B) suggest the apparent difference between tumor tissues and NAT (up) and a significant distinction between serum samples from patients with ESCC and those from healthy volunteers (down). Here, BRD2 is linked to esophageal squamous cell carcinoma.